title: Protocol #0207-544: a phase study to evaluate the safety and pharmacokinetics of Pro-1, a liposome-encapsulated thymidine kinase gene formulation, in patients with stage IV metastatic melanoma.
authors.affiliation: Seattle Cancer Care Alliance and the University of Washington, USA.
authors.forename: John
authors.initials: J
authors.lastname: Thompson
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000493:pharmacokinetics*; D002985:Clinical Protocols; D018014:Gene Transfer Techniques; D006801:Humans; D008081:Liposomes / Q000493:pharmacokinetics*; D008545:Melanoma / Q000628:therapy*; D008875:Middle Aged; D009362:Neoplasm Metastasis / Q000628:therapy*; D013937:Thymidine Kinase / Q000235:genetics* / Q000493:pharmacokinetics
chemical_list: D000970:Antineoplastic Agents; D008081:Liposomes; D013937:Thymidine Kinase